CDEK
← All drugs Report issue

contezolid

Small moleculeexperimental

Clinical trial activity

8 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
6
Phase 3
2
Phase 4
2

Earliest trial started Feb 1, 2015 (NCT02269319)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2022

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2024

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

O=C1C=CN(c2c(F)cc(N3C[C@H](CNc4ccon4)OC3=O)c(F)c2F)CC1
Mol. weight
408.34 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • mrx-i
  • mrx-i
  • mrx-i

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07084402Phase 4Jul 24, 2025Capital Medical University, MicuRx, Peking University
NCT07213765Phase 4Jul 24, 2025Anhui Medical University, Capital Medical University, Guangzhou Chest Hospital., Huazhong University of Science and Technology, Jiangxi Chest Hospital, MicuRx, Peking University
NCT06811025Phase 1/Phase 2 (Phase 2)Feb 1, 2024Capital Medical University
NCT06811012Phase 1/Phase 2 (Phase 2)Jan 31, 2024Capital Medical University
NCT06081361Phase 3Nov 1, 2023Capital Medical University
NCT05369052Phase 3May 31, 2022MicuRx
NCT03747497Phase 2Nov 15, 2018MicuRx
NCT02269319Phase 2Feb 1, 2015MicuRx
Showing 8 of 8 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Capital Medical UniversityAcademic/Hospital5532023
MicuRxFor profit5332015
Peking UniversityAcademic/Hospital2012025
Anhui Medical UniversityAcademic/Hospital1012025
Guangzhou Chest Hospital.Academic/Hospital1012025
Huazhong University of Science and TechnologyAcademic/Hospital1012025
Jiangxi Chest HospitalAcademic/Hospital1012025
7 organizations
Page 1 / 1